Gordon, M. A., D'Amato, N. C., Gu, H., Babbs, B., Wulfkuhle, J., Petricoin, E. F., . . . Richer, J. K. (2017). Synergy between androgen receptor antagonism and inhibition of mTOR and HER2 in breast cancer. Mol Cancer Ther.
Chicago Style CitationGordon, Michael A., et al. "Synergy between Androgen Receptor Antagonism and Inhibition of MTOR and HER2 in Breast Cancer." Mol Cancer Ther 2017.
MLA CitationGordon, Michael A., et al. "Synergy between Androgen Receptor Antagonism and Inhibition of MTOR and HER2 in Breast Cancer." Mol Cancer Ther 2017.
Warning: These citations may not always be 100% accurate.